Clinical Trial Update: Clinical Trial to Evaluate the Safety and Immunogenicity of the Vivaxin Vaccine for Malaria Caused by Plasmodium Vivax." [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to evaluate the safety and immunogenicity of the Vivaxin vaccine for Plasmodium vivax malaria; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Vivaxin Vaccine (Vivaxin vaccine)

Snippet

Sponsor: Federal University of Minas Gerais | Conditions: Malaria Vivax | Phase 1 | Status: NOT_YET_RECRUITING